The New CTV News App: CANADA'S MOST TRUSTED NEWS. ANYTIME. ANYWHEREDOWNLOAD
CTV News Channel
Ranbaxy Pharmaceuticals is the latest drug maker to pull all of its prescription ranitidine products from the Canadian market as Health Canada continues its investigation into an impurity known as N-nitrosodimethylamine (NDMA) in the drugs.
Drugmaker Sanofi is recalling its over-the-counter heartburn drug Zantac in the U.S. and Canada because of possible contamination.